ST-elevation acute myocardial infarction due to
... (Table 1) were normal with the exception of an elevated Creactive protein level. The patient was started on dual antiplatelet therapy with aspirin 81 mg daily and prasugrel 10 mg daily. In addition, a high-intensity statin, oral beta-blocker, and angiotensin-converting enzyme inhibitor were also ini ...
... (Table 1) were normal with the exception of an elevated Creactive protein level. The patient was started on dual antiplatelet therapy with aspirin 81 mg daily and prasugrel 10 mg daily. In addition, a high-intensity statin, oral beta-blocker, and angiotensin-converting enzyme inhibitor were also ini ...
- SCHHS Emergency Department
... 4.1 Cardiovascular a) Clinical examination of the cardiovascular system b) Interpretation of symptoms and clinical signs of the cardiovascular system c) Acute coronary syndromes (ACS) i) Approach to the patient with chest pain ii) Prehospital management iii) Low-risk chest pain iv) Stable angina v) ...
... 4.1 Cardiovascular a) Clinical examination of the cardiovascular system b) Interpretation of symptoms and clinical signs of the cardiovascular system c) Acute coronary syndromes (ACS) i) Approach to the patient with chest pain ii) Prehospital management iii) Low-risk chest pain iv) Stable angina v) ...
S06 Patho Dr Manar Heart
... patients with MIs and typically is associated with infarcts that damage 40% of the left ventricle 3. Papillary muscle dysfunction leads to post-infarct mitral regurgitation and it can result from post infarct ischemic dysfunction and later from muscle fibrosis and shortening . ...
... patients with MIs and typically is associated with infarcts that damage 40% of the left ventricle 3. Papillary muscle dysfunction leads to post-infarct mitral regurgitation and it can result from post infarct ischemic dysfunction and later from muscle fibrosis and shortening . ...
Disease of the Heart
... by lack of oxygen to heart muscle, treat with nitroglycerin to dilate coronary arteries. • Edema fluid in tissues, often caused by poor circulation ...
... by lack of oxygen to heart muscle, treat with nitroglycerin to dilate coronary arteries. • Edema fluid in tissues, often caused by poor circulation ...
Cardiovascular 20 – Ischaemic Heart Diease and Chest Pain
... o Only used when previous drugs are not safe. Don’t use in situations of low cardiac output. Side-effects include headaches and flushing. If Channel Blockers: o Reduces heart rate by reducing sinus rhythm o Improves exercise capability. o Used only if β-blockers are unable to be used. Side-eff ...
... o Only used when previous drugs are not safe. Don’t use in situations of low cardiac output. Side-effects include headaches and flushing. If Channel Blockers: o Reduces heart rate by reducing sinus rhythm o Improves exercise capability. o Used only if β-blockers are unable to be used. Side-eff ...
acute_coronary_syndromes
... in the range of 3 per 1000 inhabitants sex differences - men account for more than 90% of patients with AMI at the age under 40y. (a hormonal profile of woman has a protective effect) age differences - in patients aged under 40y. only one heart ...
... in the range of 3 per 1000 inhabitants sex differences - men account for more than 90% of patients with AMI at the age under 40y. (a hormonal profile of woman has a protective effect) age differences - in patients aged under 40y. only one heart ...
Problémový okruh 5 (Dušnost a bolest na hrudi)
... with fast deterioration to ventricular fibrillation. Defibrillation (300 J) and administration of Amiodarone 1 amp i.v. led to successful recovery of sinus rhythm which remained maintain till admission. At admission, patient is sedated and ventilated. Past history: Since 1995 hypertension, 1998 infe ...
... with fast deterioration to ventricular fibrillation. Defibrillation (300 J) and administration of Amiodarone 1 amp i.v. led to successful recovery of sinus rhythm which remained maintain till admission. At admission, patient is sedated and ventilated. Past history: Since 1995 hypertension, 1998 infe ...
ISCHEMIC HEART DISEASE
... • Sensation of pressure or burning over the sternum or near it, often but not always radiating to the left jaw, shoulder, and arm; also, chest tightness and shortness of breath. • Pain usually lasting from 0.5 to 30 minutes, often with a visceral ...
... • Sensation of pressure or burning over the sternum or near it, often but not always radiating to the left jaw, shoulder, and arm; also, chest tightness and shortness of breath. • Pain usually lasting from 0.5 to 30 minutes, often with a visceral ...
Pharmacological management of Ischaemic heart disease stroke
... Anti-platelet therapy to prevent further thrombosis Initiate reperfusion therapy with percutaneous angioplasty or thrombolysis if appropriate Secondary prevention ...
... Anti-platelet therapy to prevent further thrombosis Initiate reperfusion therapy with percutaneous angioplasty or thrombolysis if appropriate Secondary prevention ...
S0735109705017687_mmc1
... IA: Glycoprotein IIb/IIIa antagonist should be administered, in addition to aspirin and heparin, to patients in whom catheterization and percutaneous coronary intervention are planned. The glycoprotein IIb/IIIa antagonist may be ...
... IA: Glycoprotein IIb/IIIa antagonist should be administered, in addition to aspirin and heparin, to patients in whom catheterization and percutaneous coronary intervention are planned. The glycoprotein IIb/IIIa antagonist may be ...
Biochemistry - U
... Disease (CIHD) describes patients who develop progressive heart failure as a consequence of ischemic myocardial damage. In most instances, there's been a prior MI and sometimes previous coronary arterial bypass graft surgery or other interventions. Usually presents as insidious onset of CHF. 6) Defi ...
... Disease (CIHD) describes patients who develop progressive heart failure as a consequence of ischemic myocardial damage. In most instances, there's been a prior MI and sometimes previous coronary arterial bypass graft surgery or other interventions. Usually presents as insidious onset of CHF. 6) Defi ...
Pharmacological management of Ischaemic heart disease stroke
... Anti-platelet therapy to prevent further thrombosis Initiate reperfusion therapy with percutaneous angioplasty or thrombolysis if appropriate Secondary prevention ...
... Anti-platelet therapy to prevent further thrombosis Initiate reperfusion therapy with percutaneous angioplasty or thrombolysis if appropriate Secondary prevention ...
Acute Myocardial Infarction in Nephrotic Syndrome
... reported. The first report on ischaemic heart disease complicating NS was published in 1969 by Berlyne and Mallick, who described the occurrence of AMI in four patients with NS due to glomerulonephritis. 2 In cases of ACS with ST elevation, like our patient, it has been reported that intracoronary a ...
... reported. The first report on ischaemic heart disease complicating NS was published in 1969 by Berlyne and Mallick, who described the occurrence of AMI in four patients with NS due to glomerulonephritis. 2 In cases of ACS with ST elevation, like our patient, it has been reported that intracoronary a ...
1-on-1_with_the_widowmaker._Shabestari
... he developed sudden chest pain while playing the basketball. The pain was described as crushing, substernal, constant, nonradiating, and associated with shortness of breath, nausea, and one episode of vomiting. The patient had no prior episodes of similar symptoms. The patient reported his father ha ...
... he developed sudden chest pain while playing the basketball. The pain was described as crushing, substernal, constant, nonradiating, and associated with shortness of breath, nausea, and one episode of vomiting. The patient had no prior episodes of similar symptoms. The patient reported his father ha ...
National Imaging Associates, Inc. Clinical guidelines HEART
... anticipated. These guidelines apply to patients with chronic stable conditions or new but stable conditions. In many but not all of these patients, exercise testing should be done prior to consideration of a left heart catheterization. However, a positive stress test should not automatically lead to ...
... anticipated. These guidelines apply to patients with chronic stable conditions or new but stable conditions. In many but not all of these patients, exercise testing should be done prior to consideration of a left heart catheterization. However, a positive stress test should not automatically lead to ...
Drugs for Angina Pectoris, Myocardial Infarction
... 25.9 Glycoprotein IIb/IIIa inhibitors are antiplatelet agents for the treatment of myocardial ischemia. Glycoprotein IIb/IIIa inhibitors are drugs that exert an anticoagulant effect by occupying the glycoprotein IIb/IIIa receptor and inhibiting clot formation. They are of value in the prevention of ...
... 25.9 Glycoprotein IIb/IIIa inhibitors are antiplatelet agents for the treatment of myocardial ischemia. Glycoprotein IIb/IIIa inhibitors are drugs that exert an anticoagulant effect by occupying the glycoprotein IIb/IIIa receptor and inhibiting clot formation. They are of value in the prevention of ...
Myocardial infarction
... 1 year. IV beta blocker therapy should be administered within the initial hours of the evolving infarction, followed by oral therapy provided there are no contraindications. They reduce oxygen demand by decreasing the heart rate and contractility. They also increase coronary artery filling by prolon ...
... 1 year. IV beta blocker therapy should be administered within the initial hours of the evolving infarction, followed by oral therapy provided there are no contraindications. They reduce oxygen demand by decreasing the heart rate and contractility. They also increase coronary artery filling by prolon ...
The ABCs of ACS: Review of Acute Coronary Syndrome
... ACC/AHA Guidelines for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction. Revise to the 2002 Guidelines. 2007. http://circ.ahajournals.org ACC/AHA Guidelines for the Management of Patients with STElevation Myocardial Infarction. Revise to the 2004 Guidelines. ...
... ACC/AHA Guidelines for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction. Revise to the 2002 Guidelines. 2007. http://circ.ahajournals.org ACC/AHA Guidelines for the Management of Patients with STElevation Myocardial Infarction. Revise to the 2004 Guidelines. ...
About Cardiac Catheterization
... find out if a patient’s coronary artery has become constricted (angina) or if is completely blocked (myocardial infarction). A balloon catheter can be used to widen the narrow area. A small stainless metal scaffold, called a stent, can also be used to keep blood vessel open. 3. A flexible catheter i ...
... find out if a patient’s coronary artery has become constricted (angina) or if is completely blocked (myocardial infarction). A balloon catheter can be used to widen the narrow area. A small stainless metal scaffold, called a stent, can also be used to keep blood vessel open. 3. A flexible catheter i ...
RELATIONSHIP OF RETINAL ARTERIOLAR NARROWING AND …
... 28 (7.2% of total lesions treated) 24(6.2% of total lesions treated) ...
... 28 (7.2% of total lesions treated) 24(6.2% of total lesions treated) ...
CVS Pathology Lecture Notes (L2)
... atherosclerosis – narrowing of the arteries arteriosclerosis – hardening of the vessels arteriolosclerosis – hardening and thicking of walls of smaller arteries (arterioles) Complications 1. calcification 2. ulceration (cholesterol crystals and emboli) 3. thrombosis (obstruction/blocked) 4. haemorrh ...
... atherosclerosis – narrowing of the arteries arteriosclerosis – hardening of the vessels arteriolosclerosis – hardening and thicking of walls of smaller arteries (arterioles) Complications 1. calcification 2. ulceration (cholesterol crystals and emboli) 3. thrombosis (obstruction/blocked) 4. haemorrh ...
Management of acute coronary syndrome
Management of acute coronary syndrome is targeted against the effects of reduced blood flow to the afflicted area of the heart muscle, usually because of a blood clot in one of the coronary arteries, the vessels that supply oxygenated blood to the myocardium. This is achieved with urgent hospitalization and medical therapy, including drugs that relieve chest pain and reduce the size of the infarct, and drugs that inhibit clot formation; for a subset of patients invasive measures are also employed (coronary angiography and percutaneous coronary intervention). Basic principles of management are the same for all types of acute coronary syndrome. However, some important aspects of treatment depend on the presence or absence of elevation of the ST segment on the electrocardiogram, which classifies cases upon presentation to either ST segment elevation myocardial infarction (STEMI) or non-ST elevation acute coronary syndrome (NST-ACS); the latter includes unstable angina and non-ST elevation myocardial infarction (NSTEMI). Treatment is generally more aggressive for STEMI patients, and reperfusion therapy is more often reserved for them. Long term therapy is necessary for prevention of recurrent events and complications.